Addus HomeCare Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0067391062
USD
114.16
-5.91 (-4.92%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

188.12 k

Shareholding (Mar 2025)

FII

7.89%

Held by 126 FIIs

DII

41.72%

Held by 54 DIIs

Promoter

0.09%

How big is Addus HomeCare Corp.?

22-Jun-2025

As of Jun 18, Addus HomeCare Corp. has a market capitalization of $2.1 billion, with net sales of $1.2 billion and a net profit of $79 million for the latest four quarters. The balance sheet as of December 2024 shows shareholder's funds of $970.5 million and total assets of $1.5 billion.

As of Jun 18, Addus HomeCare Corp. has a market capitalization of 2,098.05 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 1,211.56 million and a net profit of 79.00 million for the latest four quarters ending in March 2025, December 2024, September 2024, and June 2024.<BR><BR>As of December 2024, the balance sheet shows shareholder's funds of 970.49 million and total assets of 1,464.42 million.

Read More

What does Addus HomeCare Corp. do?

22-Jun-2025

Addus HomeCare Corporation provides personal care services primarily in-home and operates as a micro-cap company in the Pharmaceuticals & Biotechnology industry. As of March 2025, it reported net sales of $338 million and a net profit of $21 million, with a market cap of approximately $2.1 billion.

Overview:<BR>Addus HomeCare Corporation is a provider of personal care services primarily in the home, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>- Most recent Net Sales: 338 Million (Quarterly Results - Mar 2025)<BR>- Most recent Net Profit: 21 Million (Quarterly Results - Mar 2025)<BR>- Market cap: USD 2,098.05 Million (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 23.00<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.11<BR>- Return on Equity: 9.19%<BR>- Price to Book: 2.11<BR><BR>Contact Details:<BR>- Address: 6303 COWBOYS WAY, SUITE 600, FRISCO TX : 75034<BR>- Tel: ['1 469 5358200', '1 630 2963400']<BR>- Fax: 1 302 6365454<BR>- Website: http://www.addus.com/

Read More

Who are in the management team of Addus HomeCare Corp.?

22-Jun-2025

As of March 2022, the management team of Addus HomeCare Corp. includes R. Dirk Allison (CEO), Steven Geringer (Chairman), and several independent directors: Michael Earley, Mark First, Darin Gordon, Veronica Hill-Milbourne, and Esteban Lopez. They oversee the company's operations and strategic direction.

As of March 2022, the management team of Addus HomeCare Corp. includes the following individuals:<BR><BR>- Mr. Steven Geringer, Independent Chairman of the Board<BR>- Mr. R. Dirk Allison, President, Chief Executive Officer, Director<BR>- Mr. Michael Earley, Independent Director<BR>- Mr. Mark First, Independent Director<BR>- Mr. Darin Gordon, Independent Director<BR>- Ms. Veronica Hill-Milbourne, Independent Director<BR>- Dr. Esteban Lopez, Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Read More

Should I buy, sell or hold Addus HomeCare Corp.?

22-Jun-2025

Is Addus HomeCare Corp. overvalued or undervalued?

20-Sep-2025

As of August 4, 2025, Addus HomeCare Corp. is fairly valued with a P/E ratio of 23 and has underperformed the S&P 500, indicating it is neither undervalued nor overvalued compared to peers like The Ensign Group and U.S. Physical Therapy.

As of 4 August 2025, Addus HomeCare Corp. has moved from an attractive to a fair valuation grade. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 23, an EV to EBITDA of 16.07, and a PEG ratio of 1.38, which suggest that the stock is priced in line with its earnings growth expectations.<BR><BR>In comparison to its peers, Addus HomeCare Corp. has a P/E ratio of 22.05, while The Ensign Group, Inc. is rated attractive with a significantly higher P/E of 32.46, indicating that Addus may not be as richly valued as some competitors. Additionally, U.S. Physical Therapy, Inc. also shows a fair valuation with a P/E of 28.81, further supporting the notion that Addus is neither undervalued nor overvalued in its sector. Over the past year, Addus HomeCare Corp. has underperformed the S&P 500, returning -17.14% compared to the index's 17.14%, reinforcing the view that the stock is fairly valued at this time.

Read More

Is Addus HomeCare Corp. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, Addus HomeCare Corp. is in a bearish technical trend with mixed signals, underperforming the S&P 500 with a year-to-date return of -12.40% compared to the S&P's 12.22%.

As of 12 September 2025, the technical trend for Addus HomeCare Corp. has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. The weekly MACD is bullish, but the monthly MACD is mildly bearish, indicating mixed signals. The daily moving averages are bearish, and both the weekly and monthly KST and OBV are mildly bearish. The Bollinger Bands show a sideways trend weekly but are bearish monthly. <BR><BR>In terms of performance, Addus HomeCare has underperformed the S&P 500 across multiple periods, with a year-to-date return of -12.40% compared to the S&P 500's 12.22%, and a one-year return of -17.14% against the S&P 500's 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Company has a low Debt to Equity ratio (avg) at times

 
2

Healthy long term growth as Operating profit has grown by an annual rate 21.02%

 
3

The company has declared negative results in Mar'2025 after 7 consecutive positive quarters

4

With ROE of 9.19%, it has a very expensive valuation with a 2.09 Price to Book Value

5

High Institutional Holdings at 100%

6

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 2,105 Million (Small Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.09

stock-summary
Return on Equity

9.34%

stock-summary
Price to Book

2.06

Revenue and Profits:
Net Sales:
349 Million
(Quarterly Results - Jun 2025)
Net Profit:
22 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.94%
0%
0.94%
6 Months
1.31%
0%
1.31%
1 Year
-6.58%
0%
-6.58%
2 Years
27.44%
0%
27.44%
3 Years
1.43%
0%
1.43%
4 Years
34.81%
0%
34.81%
5 Years
12.96%
0%
12.96%

Addus HomeCare Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
11.64%
EBIT Growth (5y)
21.02%
EBIT to Interest (avg)
11.92
Debt to EBITDA (avg)
0.84
Net Debt to Equity (avg)
0.12
Sales to Capital Employed (avg)
1.17
Tax Ratio
24.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
11.39%
ROE (avg)
9.00%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
2.09
EV to EBIT
17.91
EV to EBITDA
16.07
EV to Capital Employed
1.98
EV to Sales
1.81
PEG Ratio
1.38
Dividend Yield
NA
ROCE (Latest)
11.05%
ROE (Latest)
9.19%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 98 Schemes (50.21%)

Foreign Institutions

Held by 126 Foreign Institutions (7.89%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 21.78% vs 10.35% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 22.10% vs 21.48% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "349.40",
          "val2": "286.90",
          "chgp": "21.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "36.80",
          "val2": "29.60",
          "chgp": "24.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.50",
          "val2": "2.10",
          "chgp": "66.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "22.10",
          "val2": "18.10",
          "chgp": "22.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "94.10%",
          "val2": "91.20%",
          "chgp": "0.29%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 9.06% vs 11.31% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 17.76% vs 35.87% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,154.60",
          "val2": "1,058.70",
          "chgp": "9.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "129.30",
          "val2": "111.00",
          "chgp": "16.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.70",
          "val2": "11.10",
          "chgp": "-30.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-16.80",
          "val2": "-5.90",
          "chgp": "-184.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "73.60",
          "val2": "62.50",
          "chgp": "17.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "100.20%",
          "val2": "91.50%",
          "chgp": "0.87%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
349.40
286.90
21.78%
Operating Profit (PBDIT) excl Other Income
36.80
29.60
24.32%
Interest
3.50
2.10
66.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
22.10
18.10
22.10%
Operating Profit Margin (Excl OI)
94.10%
91.20%
0.29%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 21.78% vs 10.35% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 22.10% vs 21.48% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,154.60
1,058.70
9.06%
Operating Profit (PBDIT) excl Other Income
129.30
111.00
16.49%
Interest
7.70
11.10
-30.63%
Exceptional Items
-16.80
-5.90
-184.75%
Consolidate Net Profit
73.60
62.50
17.76%
Operating Profit Margin (Excl OI)
100.20%
91.50%
0.87%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 9.06% vs 11.31% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 17.76% vs 35.87% in Dec 2023

stock-summaryCompany CV
About Addus HomeCare Corp. stock-summary
stock-summary
Addus HomeCare Corp.
Pharmaceuticals & Biotechnology
Addus HomeCare Corporation is a provider of personal care services, which are provided primarily in the home. The Company's personal care services include assistance with bathing, grooming, oral care, skincare, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping and transportation services and other activities of daily living. The Company provides these non-medical services on a long-term, continuous basis. The Company delivers services to its consumers through 180 individual agencies located in 25 states. Its services, which include non-medical care, such as personal care services, are provided to consumers who are unable to independently perform some or all of their activities of daily living.
Company Coordinates stock-summary
Company Details
6303 COWBOYS WAY, SUITE 600 , FRISCO TX : 75034
stock-summary
Tel: 1 469 53582001 630 2963400
stock-summary
Registrar Details